GlaxoSmithKline

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Public

Established: 1929-01-01

Employees: 70.2K

Market Cap: $90B

Website: http://www.gsk.com

Introduction: GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Clinical Trials

Pharmacokinetics of Repeat Oral Doses of Dabrafenib and the Combination of Dabrafenib and Trametinib in Chinese Subjects With Melanoma

Phase 1

Withdrawn

Conditions: Melanoma

Interventions: Drug: Dabrafenib
Drug: Trametinib

First Posted Date: 2015-05-19

Last Posted Date: 2018-09-14

Lead Sponsor: GlaxoSmithKline

Registration Number: NCT02447939

Exploratory Study of Biotelemetry in Amyotrophic Lateral Sclerosis

Not Applicable

Completed

Conditions: Amyotrophic Lateral Sclerosis

Interventions: Device: Faros Sensor (FS) and LifeInsight Hub
Device: Fast Fix electrode patch
Procedure: Quantitative Measure of Speech (Core Phase Only)

First Posted Date: 2015-05-19

Last Posted Date: 2018-12-26

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 25

Registration Number: NCT02447952

Locations: 🇬🇧
GSK Investigational Site, Oxford, United Kingdom

Duration of Protection: GSK DTaP Vaccines

Completed

Conditions: Diphtheria
Tetanus
Acellular Pertussis

Interventions: Biological: Infanrix
Biological: Pediarix
Biological: Kinrix

First Posted Date: 2015-05-19

Last Posted Date: 2015-11-01

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 1

Registration Number: NCT02447978

A Bioequivalence Study of Cefadroxil Film Coated Tablets After A Single Oral Dose Administration to Healthy Subjects

Phase 4

Completed

Conditions: Infections, Urinary Tract

Interventions: Drug: Cefadroxil tablets manufactured by GSK
Drug: Cefadroxil tablets manufactured by NP

First Posted Date: 2015-05-18

Last Posted Date: 2017-09-21

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 24

Registration Number: NCT02446496

Locations: 🇪🇬
GSK Investigational Site, Cairo, Egypt

Follow-up Study to Investigate the Effect of GSK2245035 on Nasal Allergic Reactivity in Subjects Completing Treatment in Study TL7116958

Phase 2

Completed

Conditions: Asthma and Rhinitis

Interventions: Other: Pollen allergen extract

First Posted Date: 2015-05-18

Last Posted Date: 2018-04-04

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 16

Registration Number: NCT02446613

Locations: 🇨🇦
GSK Investigational Site, Kingston, Ontario, Canada

Evaluation of Antibody Persistence Following 4 MenACWY Vaccinations

Phase 4

Completed

Conditions: Infections, Meningococcal

Interventions: Biological: MenACWY

First Posted Date: 2015-05-18

Last Posted Date: 2019-06-27

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 128

Registration Number: NCT02446691

Locations: 🇰🇷
GSK Investigational Site, Seoul, Korea, Republic of

A Study to Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants

Phase 3

Completed

Conditions: Infections, Streptococcal

Interventions: Biological: Pneumococcal vaccine GSK1024850A (10Pn-PD-DiT) vaccine (1-dose presentation)
Biological: Pneumococcal vaccine GSK1024850A (10Pn-PD-DiT) vaccine (4-dose presentation)
Biological: DTPw-HBV/Hib